Skip to main content

Sullivan Lara's Form 4 filing

Pyxis Oncology, Inc.PYXS · filed Sep 13, 2023

Accession no.
0001209191-23-049366
Filed
Sep 13, 2023
Trade date
Sep 11-13, 2023
Filing delay
2 days
Rule 10b5-1 plan
Not checked

This filing lists 4 non-derivative transactions. Open-market sales total $63.3K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Sullivan LaraCIK 0001769457Director, Officer (President and CEO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Sep 11, 2023Common StockSSaleDisposed−20,000$2.27F1,F2−$45,4002,605,182Direct
Sep 12, 2023Common StockSSaleDisposed−4,917$2.25F1,F3−$11,063.252,600,265Direct
Sep 13, 2023Common StockSSaleDisposed−3,000$2.27F1,F4−$6,8102,597,265Direct
Sep 13, 2023Common StockFTax withholdingDisposed−184,742$2.13−$393,500.462,412,523Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

Reflects sales of common stock executed in multiple transactions. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected within the ranges set forth in footnotes 2 through 4 of this Form 4.

Referenced by the price of 3 transactions in Table I.

F2

The transaction was executed in multiple trades in prices ranging from $2.13 to $2.36.

Referenced by the price of 1 transaction in Table I.

F3

The transaction was executed in multiple trades in prices ranging from $2.21 to $2.30.

Referenced by the price of 1 transaction in Table I.

F4

The transaction was executed in multiple trades in prices ranging from $2.25 to $2.34.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)